Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MediClear Scar
- Development stage
- Unknown
- Lead developer
- Covalon Technologies
- Administration
- Topical
01
Overview
MediClear Scar is a medical device developed by Covalon Technologies Ltd. for the prophylactic treatment and management of hypertrophic and keloid scars. It consists of a thin, transparent polyurethane film coated with a soft silicone adhesive gel. The device is designed to be applied topically to closed wounds, including those resulting from surgery or burns. By providing a protective barrier that intimately adheres to the skin's contours, it maintains a moist environment and applies gentle pressure, which helps to soften, flatten, and fade scar tissue. It is intended for continuous wear for up to seven days and is discreet enough for use on visible areas.
- Brand names
- MediClear Scar
Beyond the preview
Go deeper on MediClear Scar.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MediClear Scar.